• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization.骨硬化蛋白在老年小鼠的破骨细胞中表达,并减少破骨细胞介导的矿化刺激。
J Cell Biochem. 2013 Aug;114(8):1901-1907. doi: 10.1002/jcb.24537.
2
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.破骨细胞对骨形成的调节涉及Wnt/骨形态发生蛋白信号通路和趋化因子鞘氨醇-1-磷酸。
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20764-9. doi: 10.1073/pnas.0805133106. Epub 2008 Dec 15.
3
TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.TGF-β 诱导雌性小鼠破骨细胞中 Wnt10b 的表达,从而增强与成骨细胞的偶联。
Endocrinology. 2013 Oct;154(10):3745-52. doi: 10.1210/en.2013-1272. Epub 2013 Jul 16.
4
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.骨硬化蛋白通过 RANKL 依赖性途径刺激骨细胞支持破骨细胞活性。
PLoS One. 2011;6(10):e25900. doi: 10.1371/journal.pone.0025900. Epub 2011 Oct 4.
5
Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts.骨形成与吸收通过破骨细胞抑制骨硬化蛋白表达耦联。
J Bone Miner Res. 2017 Oct;32(10):2074-2086. doi: 10.1002/jbmr.3175. Epub 2017 Jun 15.
6
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
7
Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.磷酸酶 PHLPP1 的缺乏抑制破骨细胞介导的骨吸收并增强小鼠的骨形成。
J Biol Chem. 2019 Aug 2;294(31):11772-11784. doi: 10.1074/jbc.RA119.007660. Epub 2019 Jun 12.
8
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.骨硬化蛋白是一种局部作用的晚期成骨细胞/前骨细胞分化调节剂,通过 MEPE-ASARM 依赖机制调节矿化。
J Bone Miner Res. 2011 Jul;26(7):1425-36. doi: 10.1002/jbmr.345.
9
Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.甲状旁腺激素持续升高通过破骨细胞依赖和非依赖机制增加成骨细胞数量。
J Bone Miner Res. 2010 Nov;25(11):2427-37. doi: 10.1002/jbmr.145.
10
The transient receptor potential channel TRPV6 is dynamically expressed in bone cells but is not crucial for bone mineralization in mice.瞬时受体电位通道 TRPV6 在骨细胞中动态表达,但对小鼠的骨矿化并非至关重要。
J Cell Physiol. 2012 May;227(5):1951-9. doi: 10.1002/jcp.22923.

引用本文的文献

1
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases.适配体作为衰老及衰老相关疾病的诊断和治疗剂
Biosensors (Basel). 2025 Apr 5;15(4):232. doi: 10.3390/bios15040232.
2
The bone microenvironment: new insights into the role of stem cells and cell communication in bone regeneration.骨微环境:干细胞及细胞通讯在骨再生中作用的新见解
Stem Cell Res Ther. 2025 Apr 12;16(1):169. doi: 10.1186/s13287-025-04288-4.
3
An in silico approach to elucidate the pathways leading to primary osteoporosis: age-related vs. postmenopausal.一种阐明导致原发性骨质疏松症的途径的计算方法:与年龄相关的与绝经后相关的。
Biomech Model Mechanobiol. 2024 Aug;23(4):1393-1409. doi: 10.1007/s10237-024-01846-2. Epub 2024 May 3.
4
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia.靶向肌肉-骨骼-脂肪组织信号通路的相互作用:治疗肌少症的一种有前途的治疗方法。
Aging Dis. 2024 Aug 1;15(4):1619-1645. doi: 10.14336/AD.2023.00903.
5
Exercise-Linked Skeletal Irisin Ameliorates Diabetes-Associated Osteoporosis by Inhibiting the Oxidative Damage-Dependent miR-150-FNDC5/Pyroptosis Axis.运动相关的骨丝氨酸鸢尾素通过抑制氧化损伤依赖的 miR-150-FNDC5/细胞焦亡轴改善糖尿病相关骨质疏松症。
Diabetes. 2022 Dec 1;71(12):2777-2792. doi: 10.2337/db21-0573.
6
Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact.骨细胞暴露于钛颗粒中,通过直接的细胞间接触,增加骨钙素蛋白的表达并抑制成骨细胞的分化。
J Cell Mol Med. 2022 Aug;26(15):4371-4385. doi: 10.1111/jcmm.17460. Epub 2022 Jun 28.
7
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.Wnt 通路细胞外成分及其在骨稳态中的重要作用。
Genes (Basel). 2022 Jan 13;13(1):138. doi: 10.3390/genes13010138.
8
Recent Advances in Osteoclast Biological Behavior.破骨细胞生物学行为的最新进展
Front Cell Dev Biol. 2021 Dec 8;9:788680. doi: 10.3389/fcell.2021.788680. eCollection 2021.
9
Trabecular bone organoids: a micron-scale 'humanised' prototype designed to study the effects of microgravity and degeneration.小梁骨类器官:一种旨在研究微重力和退变影响而设计的微米级“人源化”原型。
NPJ Microgravity. 2021 May 21;7(1):17. doi: 10.1038/s41526-021-00146-8.
10
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.骨骼衰老与骨质疏松症:机制与治疗。
Int J Mol Sci. 2021 Mar 29;22(7):3553. doi: 10.3390/ijms22073553.

本文引用的文献

1
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.基质 IGF-1 通过激活间充质干细胞中的 mTOR 来维持骨量。
Nat Med. 2012 Jul;18(7):1095-101. doi: 10.1038/nm.2793.
2
Age-related changes in gap junctional intercellular communication in osteoblastic cells.成骨细胞缝隙连接细胞间通讯的年龄相关性变化。
J Orthop Res. 2012 Dec;30(12):1979-84. doi: 10.1002/jor.22172. Epub 2012 Jun 13.
3
Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging.加速衰老小鼠模型中端粒功能障碍与增殖无关导致成骨细胞分化受损。
Aging Cell. 2012 Aug;11(4):704-13. doi: 10.1111/j.1474-9726.2012.00838.x. Epub 2012 Jun 11.
4
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.哺乳期小鼠破骨细胞性骨陷窝/骨小管改建的示踪研究。
J Bone Miner Res. 2012 May;27(5):1018-29. doi: 10.1002/jbmr.1567.
5
Examination of nuclear receptor expression in osteoblasts reveals Rorβ as an important regulator of osteogenesis.检测成骨细胞中核受体的表达情况,揭示 Rorβ 是成骨作用的一个重要调节因子。
J Bone Miner Res. 2012 Apr;27(4):891-901. doi: 10.1002/jbmr.1502.
6
Osteoporosis: now and the future.骨质疏松症:现在与未来。
Lancet. 2011 Apr 9;377(9773):1276-87. doi: 10.1016/S0140-6736(10)62349-5. Epub 2011 Mar 28.
7
Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.骨硬化蛋白对骨形态发生蛋白和 Wnt 信号通路的抑制作用具有不同模式。
J Biol Chem. 2010 Dec 31;285(53):41614-26. doi: 10.1074/jbc.M110.153890. Epub 2010 Oct 15.
8
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.年龄、性别和骨量与男性及女性循环中硬化素水平的关系。
J Bone Miner Res. 2011 Feb;26(2):373-9. doi: 10.1002/jbmr.217.
9
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.AMG 785,一种硬骨素单克隆抗体的单次剂量、安慰剂对照、随机研究。
J Bone Miner Res. 2011 Jan;26(1):19-26. doi: 10.1002/jbmr.173.
10
Effects of chronic estrogen treatment on modulating age-related bone loss in female mice.慢性雌激素治疗对调节雌性小鼠与年龄相关的骨丢失的影响。
J Bone Miner Res. 2010 Nov;25(11):2438-46. doi: 10.1002/jbmr.129.

骨硬化蛋白在老年小鼠的破骨细胞中表达,并减少破骨细胞介导的矿化刺激。

Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization.

机构信息

Endocrine Research Unit and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, 55905.

Division of Orthopedic Research, Mayo Clinic, Rochester, MN, 55905.

出版信息

J Cell Biochem. 2013 Aug;114(8):1901-1907. doi: 10.1002/jcb.24537.

DOI:10.1002/jcb.24537
PMID:23494985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3895454/
Abstract

Osteoclast-mediated bone resorption precedes osteoblast-mediated bone formation through early adulthood, but formation fails to keep pace with resorption during aging. We previously identified several factors produced by osteoclasts that promote bone formation. In this study, we determined if osteoclast-produced factors contribute to the impaired bone formation with aging. We previously found that mice between the ages of 18 and 22 months develop age-related bone loss. Bone marrow-derived pre-osteoclasts were isolated from 6-week, 12-month, and 18- to 24-month-old mice and differentiated into osteoclasts in vitro. Conditioned media were collected and compared for osteoblast mineralization support. Conditioned medium from osteoclasts from all ages was able to support mineralization of bone marrow stromal cells. Concentrating the conditioned medium from 6-week-old and 12-month-old mouse marrow cells-derived osteoclasts enhanced mineralization support whereas concentrated conditioned medium from 18- to 24-month-old mouse marrow-derived osteoclasts repressed mineralization compared to base medium. This observation suggests that an inhibitor of mineralization was secreted by aged murine osteoclasts. Gene and protein analysis revealed that the Wnt antagonist sclerostin was significantly elevated in the conditioned media from 24-month-old mouse cells compared to 6-week-old mouse cells. Antibodies directed to sclerostin neutralized the influences of the aged mouse cell concentrated conditioned media on mineralization. Sclerostin is primarily produced by osteocytes in young animals. This study demonstrates that osteoclasts from aged mice also produce sclerostin in quantities that may contribute to the age-related impairment in bone formation.

摘要

破骨细胞介导的骨吸收先于成骨细胞介导的骨形成,贯穿整个成年期,但在衰老过程中,骨形成跟不上骨吸收的速度。我们之前已经鉴定出几种由破骨细胞产生的促进骨形成的因子。在这项研究中,我们确定了破骨细胞产生的因子是否有助于解释衰老导致的骨形成受损。我们之前发现,年龄在 18 至 22 个月的小鼠会出现与年龄相关的骨质流失。从 6 周龄、12 月龄和 18-24 月龄的小鼠中分离骨髓来源的前破骨细胞,并在体外分化为破骨细胞。收集并比较条件培养基对成骨细胞矿化的支持作用。来自所有年龄段的破骨细胞的条件培养基均能支持骨髓基质细胞的矿化。浓缩来自 6 周龄和 12 月龄小鼠骨髓细胞衍生破骨细胞的条件培养基增强了矿化支持作用,而浓缩来自 18-24 月龄小鼠骨髓衍生破骨细胞的条件培养基则抑制了矿化作用,与基础培养基相比。这一观察结果表明,老年鼠破骨细胞分泌了一种矿化抑制剂。基因和蛋白质分析显示,与 6 周龄小鼠细胞相比,来自 24 月龄小鼠细胞的条件培养基中 Wnt 拮抗剂骨硬化蛋白显著升高。针对骨硬化蛋白的抗体中和了来自老年鼠细胞浓缩条件培养基对矿化的影响。骨硬化蛋白主要由幼小动物的成骨细胞产生。本研究表明,老年小鼠的破骨细胞也产生大量的骨硬化蛋白,这可能导致与年龄相关的骨形成受损。